Literature DB >> 10949909

Induction of neonatal tolerance to oxidized lipoprotein reduces atherosclerosis in ApoE knockout mice.

A Nicoletti1, G Paulsson, G Caligiuri, X Zhou, G K Hansson.   

Abstract

BACKGROUND: In the course of atherosclerosis, humans and apolipoprotein (apoE) Knockout (KO) mice exhibit an active cell-mediated and humoral immune process, both at the systemic level and within atheromata. Low density lipoproteins (LDL) infiltrate the vascular wall, where they are oxidatively modified. This oxidative modification may generate new epitopes for which tolerance is not achieved during ontogenesis. Such epitopes could constitute new targets for autoreactive immune responses that may have a physiopathological role in disease development.
MATERIALS AND METHODS: Exposing mice to high dose of antigens during thymic T-cell education induces immunological tolerance to the administered antigens. We injected newborn apoE KO mice with oxidized LDL. They were fed a cholesterol-rich diet and aortic atherosclerosis, cell-mediated immune response, and T-cell repertoire were analyzed after 5 months.
RESULTS: Injection of oxidized LDL at birth reduced not only the immune response to oxidized LDL, but also susceptibility to atherosclerosis in apoE mice. Injection of oxidized LDL induced T-cell tolerance due to clonal deletion, rather than anergy of the reactive T cells. The T-cell repertoire of apoE KO mice was affected by the development of the disease, whereas tolerization normalized it.
CONCLUSIONS: This study demonstrates that the immune response against oxidized LDL has a deleterious role in atherogenesis and that a fine-tuning of this response could modify the course of the disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949909      PMCID: PMC1949951     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  5 in total

1.  Inhibition of foam cell formation using a soluble CD68-Fc fusion protein.

Authors:  Karin Daub; Dorothea Siegel-Axel; Tanja Schönberger; Christoph Leder; Peter Seizer; Karin Müller; Martin Schaller; Sandra Penz; Dagmar Menzel; Berthold Büchele; Andreas Bültmann; Götz Münch; Stephan Lindemann; Thomas Simmet; Meinrad Gawaz
Journal:  J Mol Med (Berl)       Date:  2010-05-08       Impact factor: 4.599

Review 2.  Immunomodulation of vascular diseases: atherosclerosis and autoimmunity.

Authors:  G-P Shi
Journal:  Eur J Vasc Endovasc Surg       Date:  2010-02-25       Impact factor: 7.069

Review 3.  Linking immunity to atherosclerosis: implications for vascular pharmacology--a tribute to Göran K. Hansson.

Authors:  Yong-Jian Geng; Lena Jonasson
Journal:  Vascul Pharmacol       Date:  2011-11-20       Impact factor: 5.773

Review 4.  Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics.

Authors:  Michael Jan; Shu Meng; Natalie C Chen; Jietang Mai; Hong Wang; Xiao-Feng Yang
Journal:  J Biomed Biotechnol       Date:  2010-04-15

5.  Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis.

Authors:  Andreas Hermansson; Daniel F J Ketelhuth; Daniela Strodthoff; Marion Wurm; Emil M Hansson; Antonino Nicoletti; Gabrielle Paulsson-Berne; Göran K Hansson
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.